Media Centre


New prospective open-label study on anidulafungin for invasive candidiasis in children

February 27 2019

Recommendations for using anidulafungin (Ecalta/Eraxis) to treat invasive candidiasis in children are largely extrapolated from trials in adults. Dr Roilides and colleagues have published data from a trial of 49 children reporting a global response rate of 71% and a drug-related adverse event rate of 37% (10% discontinued due to AEs).
Read more

Rapid detection of by qPCR in a wide range of clinical specimens: has culture had its day?

February 20 2019

An evaluation of a qPCR test for Coccidioides showed good sensitivity (74%) and specificity (100%), and produced results within 4 hours - outperforming fungal culture.
Read more

Using mobile phone reminders for medication

February 15 2019

Forgetting to take medication can be a major barrier to successful treatment; this problem is exacerbated when the treatment dosing is infrequent.
Read more

Candida africana in recurrent vulvovaginal candidiasis patients

February 08 2019

Recurrent vulvovaginal candidiasis (RVVC) is a condition which, though not linked to mortality, can cause complications and significant psychological, physical and monetary costs.
Read more

Fungal Infection Care Ghana’s CPA Awareness Seminar on World Aspergillosis Day

February 07 2019

On February 1st World Aspergillosis Day was marked around the world, with several events occurring. In Ghana, Fungal Infections Care (FIC) held a seminar to raise awareness of chronic pulmonary aspergillosis (CPA).
Read more

 < 1 2 3 4 >  Last ›